Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Adrenoleukodystrophy (Phase 2)
alpha-Thalassemia (Phase 1/Phase 2)
Amenorrhea (Phase 2)
Anemia (Phase 1)
Anemia, Aplastic (Phase 2)
Anemia, Diamond-Blackfan (Phase 1/Phase 2)
Anemia, Sickle Cell (Phase 1/Phase 2)
Arthritis, Rheumatoid (Phase 1)
beta-Thalassemia (Phase 1/Phase 2)
Blood Transfusion (Phase 1/Phase 2)
Bone Marrow Failure Disorders (Phase 1/Phase 2)
Bone Marrow Transplantation (Phase 3)
Carcinoma, Renal Cell (Phase 2)
Crohn Disease (Phase 1)
Deficiency Diseases (Phase 2)
Fanconi Anemia (Phase 1/Phase 2)
Gangliosidosis, GM1 (Phase 2)
Genetic Diseases, Inborn (Phase 4)
Graft vs Host Disease (Phase 2)
Heart Transplantation (Phase 1/Phase 2)
Hematologic Diseases (Phase 1/Phase 2)
Hematologic Neoplasms (Phase 2)
Hemoglobinopathies (Phase 1)
Histiocytosis, Langerhans-Cell (Phase 2/Phase 3)
Hodgkin Disease (Phase 2)
Hydrops Fetalis (Phase 1)
Immune System Diseases (Early Phase 1)
Infections (Phase 2)
Intestinal Neoplasms (Phase 2)
Kidney Transplantation (Phase 1/Phase 2)
Leukemia (Phase 2/Phase 3)
Leukemia, Biphenotypic, Acute (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 2)
Leukemia, Myeloid (Phase 1/Phase 2)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (Phase 1/Phase 2)
Leukemia, Myeloid, Chronic-Phase (Phase 2)
Leukodystrophy, Globoid Cell (Phase 2)
Leukodystrophy, Metachromatic (Phase 2)
Liver Cirrhosis, Biliary (Phase 1)
Lupus Erythematosus, Systemic (Phase 2)
Lymphoma (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Lymphoproliferative Disorders (Phase 1/Phase 2)
Mucolipidoses (Phase 2)
Mucopolysaccharidosis III (Phase 2)
Multiple Myeloma (Phase 2)
Multiple Sclerosis (Phase 3)
Myelodysplastic Syndromes (Phase 3)
Myeloproliferative Disorders (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Ovarian Diseases (Phase 2)
Paraproteinemias (Phase 1/Phase 2)
Pharmacokinetics (Phase 4)
Precancerous Conditions (Phase 2)
Primary Myelofibrosis (Phase 2)
Primary Ovarian Insufficiency (Phase 2)
Renal Insufficiency (Phase 2)
Retinal Diseases (Phase 1)
Sandhoff Disease (Phase 2)
Tay-Sachs Disease (Phase 2)
Thalassemia (Phase 1/Phase 2)
Vascular Grafting (Phase 2)
Wiskott-Aldrich Syndrome (Phase 1)
Wolman Disease (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue